Emi Minejima

Dr. Emi Minejima is an Associate Professor of Clinical Pharmacy at the University of Southern California School of Pharmacy, specializing in infectious diseases and antimicrobial stewardship. She has been with USC since 2012 and maintains clinical practice at Los Angeles County+USC Medical Center.

Dr. Minejima earned her BS in Molecular and Cell Biology from University of California-Berkeley (2005) and her PharmD from University of California-San Diego School of Pharmacy (2009). She completed postgraduate residency training in pharmacy practice and infectious disease at Huntington Hospital in Pasadena.

Her research focuses on infectious disease pharmacotherapy, particularly Staphylococcus aureus bacteremia, antimicrobial resistance, and stewardship. Dr. Minejima investigates host immune responses to infections, vancomycin dosing strategies, and the impact of socioeconomic factors on sepsis outcomes. Her work bridges clinical practice with research to optimize antimicrobial use and improve patient outcomes.

Analysis of Dr. Minejima's recent publications reveals a strong focus on Staphylococcus aureus bacteremia, antimicrobial stewardship, and the relationship between host immune responses and infection outcomes. She has made significant contributions to understanding optimal vancomycin dosing and the clinical implications of new antimicrobial susceptibility testing breakpoints.

Dr. Minejima serves as a preceptor for pharmacy students and residents in acute care medicine and infectious disease clerkships at LAC+USC Medical Center. Her antimicrobial stewardship work directly impacts clinical practice through evidence-based interventions to optimize antibiotic use.